Extended Data Fig. 2: Representative clinical responses.

a, Tumor imaging scans of GT-30 patients #17, #7, and #18 categorized as CR, CR and PR, respectively at various treatment time-points. Red arrows point at the tumor location. b-d, Change in target lesion from baseline (%) in three patients (Pt) #17 (CR), Pt #7 (CR), and Pt #18 (PR) evaluated by RECIST 1.1.